Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease.

Gralnick HR, Rick ME.

N Engl J Med. 1983 Jun 9;308(23):1393-5.

PMID:
6405274
2.

Danazol fails to increase factor VIII or IX levels in a double-blind crossover study of patients with haemophilia A and B.

Nugent DJ, Bray GL, Counts RB, Clements MJ, Thompson AR.

Br J Haematol. 1986 Nov;64(3):493-502.

PMID:
3098273
3.

Danazol-induced factor VIII and IX bypassing activity in hemophiliacs.

Garewal HS, Corrigan JJ Jr, Jeter MA, Damiano ML, Durie BG.

Thromb Res. 1985 Jul 1;39(1):117-25.

PMID:
3929420
5.

Effect of stanozolol on factors VIII and IX and serum aminotransferases in haemophilia.

Greer IA, Greaves M, Madhok R, McLoughlin K, Porter N, Lowe GD, Preston FE, Forbes CD.

Thromb Haemost. 1985 Jun 24;53(3):386-9.

PMID:
3931287
6.

Danazol therapy in haemophilia.

Heaton DC, Wyld PJ, Conder JL.

N Z Med J. 1986 Mar 26;99(798):185-7.

PMID:
3517712
7.

Benefits of danazol treatment in patients with hemophilia A (classic hemophilia).

Gralnick HR, Maisonneuve P, Sultan Y, Rick ME.

JAMA. 1985 Feb 22;253(8):1151-3.

PMID:
3918188
8.

Poor response to danazol in hemophilia.

Kasper CK, Boylen AL.

Blood. 1985 Jan;65(1):211-3.

9.

The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay.

Matsumoto T, Shima M, Takeyama M, Yoshida K, Tanaka I, Sakurai Y, Giles AR, Yoshioka A.

J Thromb Haemost. 2006 Feb;4(2):377-84.

10.

Danazol in Indian haemophiliacs.

Sundar S, Moorleedhur-Singh GS, Dube B, Singh VP, Kumar K.

J Assoc Physicians India. 1993 Jan;41(1):23-5.

PMID:
8340322
11.

Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX.

Nilsson IM, Hedner U.

Scand J Haematol. 1976 May;16(5):369-82.

PMID:
951577
12.

Epsilon-Aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double blind controlled trial.

Walsh PN, Rizza CR, Matthews JM, Eipe J, Kernoff PB, Coles MD, Bloom AL, Kaufman BM, Beck P, Hanan CM, Biggs R.

Br J Haematol. 1971 May;20(5):463-75. No abstract available.

PMID:
4931484
13.

Effect of danazol on coagulation parameters and bleeding in hemophilia.

Garewal HS, Corrigan JJ Jr, Durie BG, Jeter MA, Damiano ML.

JAMA. 1985 Feb 22;253(8):1154-6.

PMID:
3968845
14.
15.

Orthotopic liver transplantation in a patient with combined hemophilia A and B.

Delorme MA, Adams PC, Grant D, Ghent CN, Walker IR, Wall WJ.

Am J Hematol. 1990 Feb;33(2):136-8.

PMID:
2105634
16.

Serial changes in the coagulation system following clotting factor concentrate infusion.

Preston FE, Winfield DA, Malia RG, Blackburn EK.

Thromb Diath Haemorrh. 1975 Nov 15;34(2):475-82.

PMID:
1198408
17.

A randomized placebo-controlled double-blind study of danazol in hemophilia A.

Mehta J, Singhal S, Kamath MV, Mehta BC.

Acta Haematol. 1992;88(1):14-6.

PMID:
1414156
18.

A comparison of coagulation factor replacement with and without prednisolone in the treatment of haematuria in haemophilia and Christmas disease.

Rizza CR, Kernoff PB, Matthews JM, McLennan CR, Rainsford SG.

Thromb Haemost. 1977 Feb 28;37(1):86-90.

PMID:
320712
19.

Bleeding symptoms in carriers of hemophilia A and B.

Mauser Bunschoten EP, van Houwelingen JC, Sjamsoedin Visser EJ, van Dijken PJ, Kok AJ, Sixma JJ.

Thromb Haemost. 1988 Jun 16;59(3):349-52.

PMID:
2847347
20.

The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.

McMillan CW, Greene WB, Blatt PM, White GC 2nd, Roberts HR.

Instr Course Lect. 1983;32:210-6.

PMID:
6443730

Supplemental Content

Support Center